ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Adenocarcinoma
Cancer
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Lung Cancer

Pancreatic Cancer trials near London, England, GBR:

Surveillance of Pancreatic Health After Diabetes Diagnosis (SAFE-D)

The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer...

Enrolling
Pancreatic Cancer, Adult
Diabetes Mellitus
Device: Avantect Pancreatic Cancer Test
University Hospital Southampton NHS Foundation Trust

London, United Kingdom and 13 other locations

This is an open-label, multi-centre, randomised, stratified, phase IIb clinical trial of ATRA administered in combination with gemcitabine and nab-pa...

Active, not recruiting
Pancreatic Cancer
Drug: nab-paclitaxel
Drug: Gemcitabine

Phase 2

Queen Mary University of London

London, United Kingdom

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: AMG 193
Drug: Gemcitabine

Phase 1

Amgen
Amgen

London, United Kingdom and 76 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

London, City Of London, United Kingdom and 91 other locations

is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: OncoSil™
Drug: FOLFIRINOX chemotherapy

Phase 2

OncoSil Medical

London, United Kingdom and 16 other locations

This is a study designed to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of WEF-001 as monotherapy in patients with Adv...

Enrolling
Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
Advanced Solid Tumors
Drug: WEF-001

Phase 1, Phase 2

Auricula Biosciences Inc.

Headington, Oxford, United Kingdom and 2 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Active, not recruiting
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Sutton, United Kingdom and 67 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Active, not recruiting
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Partner Therapeutics

London, United Kingdom and 63 other locations

This is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the...

Active, not recruiting
Low Grade Serous Ovarian Cancer
Pancreatic Cancer
Drug: VS-6766
Drug: Defactinib

Phase 1

Institute of Cancer Research, United Kingdom

London, United Kingdom and 4 other locations

efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/...

Enrolling
Advanced Solid Malignancies
Drug: Datopotamab Deruxtecan (Dato-DXd)
Drug: AZD9574

Phase 1, Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 32 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems